Ledger.Open graph →
SEC Form D · filed November 7, 2023

Kyverna Therapeutics, Inc

Offering
$152.0M
Sold
$152.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
EMERYVILLE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Fred Cohen · Menlo Park, CADirectorRyan Jones · Montreal, Quebec, CanadaExecKaren Walker · Emeryville, CAExecJames Chung · IRVINE, CAExecBeth Spiegelman · Emeryville, CADirectorRyan Jones · Clearwater Beach, FLExecDominic Borie · Emeryville, CAExecBrian Kotzin · Emeryville, CADirectorJames Chung · New York, NYExecDan Spiegelman · Emeryville, CADirectorBeth Spiegelman · Emeryville, CADirectorBrian Kotzin · Emeryville, CADirectorDan Spiegelman · Emeryville, CADirectorSteve Liapis · Emeryville, CADirectorIan Clark · Tuckahoe, NYDirectorDominic Borie · Emeryville, CAExecSteve Liapis · Emeryville, CADirectorPeter Maag · West Palm Beach, FLExec · DirectorPeter Maag · Emeryville, CAExec · DirectorKaren Walker · Emeryville, CAExecIan Clark · New Rochelle, NYDirectorFred Cohen · Menlo Park, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗